Submission Period: April 15, 2020 - July 30, 2020. The submission portal closes at 1:00 pm (CDT) on Thursday, July 30, 2020.
NANS Members: You can log in to the abstract submission site using your NANS username and password. Non-Members: If you have previously submitted an abstract, you may already have a username and password. If you cannot remember your username and password, please contact Member Services at 847.375.4714 or info@neuromodulation.org for assistance in obtaining your credentials. For registration purposes, it is critical that you do not create a duplicate membership record. If you are not a member and/or have not used the abstract submission site before, you can register to create an account here.
Submit an Abstract
Thursday, July 30, 2020, at 1:00 pm (CDT).
If the same abstract is submitted more than once for the 2021 Annual Meeting, then all versions of the abstracts will be subject to automatic rejection. Duplicate submissions under separate categories will be subject to automatic rejection as well. For example, do not submit the same abstract under the Late-Breaking Abstract category and the Scientific Abstract category. In order to avoid more than one submission of the same abstract, please make sure all authors agree on only one abstract submitter.
Submitters will be required to select one (1) of the following categories on the abstract submission form. Please see all the topics below to determine your abstract category:
Scientific Abstracts:
Medically Challenging Cases:
Late-Breaking Abstract:
Oral Presentations — The highest-ranked abstracts are selected for an Oral Presentation in one of the Thematic Oral Abstract Sessions or Concurrent Sessions. The highest-ranked Late-Breaking Abstracts will be selected for an Oral Presentation. These sessions are awarded CME credits, and take place during the meeting on Friday and Saturday.
Paper Posters — Highly ranked abstracts accepted for a Paper Poster Presentation will present their work on individually assigned poster boards during the interactive poster session. The Presenting Author of an abstract accepted for a Paper Poster Presentation is responsible for printing the poster and bringing it with them to the meeting. The paper poster session is a non-CME session. There are no restrictions on the financial relationships of the Presenting Author for abstracts accepted as a Paper Poster Presentation.
E-Posters — Some abstracts will only receive an acceptance for an Electronic Poster (E-poster). However, all accepted abstracts are required to submit an E-poster of their abstract to be included in our meeting publications. There will not be moderated sessions or physical presentations of E-posters during the meeting. E-posters are available during the entirety of the NANS Annual Meeting. They will be available to view on monitors at the meeting, in the NANS Annual Meeting App, and on the meeting web page. All accepted abstracts will be published electronically in the society’s journal, Neuromodulation: Technology at the Neural Interface, following the meeting.
Abstract Organizer — This role should be selected if you are an individual submitting the abstract on behalf of the Presenting Author and Co-Authors. Please note: this role is not an author of the abstract. Any name assigned this role will not be published or listed anywhere as an author of the abstract. During the submission process, select this role on the "People Associated with this Abstract" page.
Presenting Author — The Presenting Author is the person who will present the accepted abstract at the Annual Meeting. All correspondence, including acceptance letters, will be sent via email to the Presenting Author. All abstracts must have a Presenting Author designated in order to complete the submission. Presenting Authors are responsible for the E-poster submission costs and printing costs for paper posters.
Co-Authors — Each abstract can have a maximum of 25 authors. Full names with credentials, contact information, city, and state or country must be included for all authors. After successful submission of the abstract, all Co-Authors will receive an email notification about the abstract submission. They will also receive an email to complete a required Disclosure of Conflict of Interest Form. It is imperative that email addresses for all authors are correct.
Title — The title will be published in meeting materials. As an example, a properly formatted title would read: "Programming Optimization Strategies for Burst May Improve Outcomes," not "Programming optimization strategies for burst may improve outcomes."
Abstract Body — This includes an Introduction, Methods, Results, and Conclusion.
Length — Should not exceed 400 words.
References — Include any references that were used in preparing the abstract.
Figures — Charts, graphs, or images can be submitted. File(s) must be in .jpg, .gif, or .png format.
Additional Information — You will need to provide three keywords that describe your abstract.
Disclosure of Conflict of Interest — The Abstract Submitter, Presenting Author, and all Co-Authors of the submitted abstract are required to complete the Disclosure of Conflict of Interest Form, as well as an agreement with the Terms and Conditions.
CME Requirements — Abstracts accepted for the 2021 NANS Annual Meeting cannot contain advertising, logos, trade names, or a product-group message. To ensure all scientific content is free from commercial bias, please include generic names or terms in your abstract content. If the abstract includes trade names, names from several companies should be used to present all available treatment options.
Review Work — All abstract details, including author information, will be published exactly as submitted, without exception. Please review submissions carefully for typographical errors.
Once your abstract has been submitted, the NANS Staff is not responsible for making any edits and/or changes on your behalf.
Submit — A confirmation letter will be sent after successful submission of the abstract.
Abstract Submitters may make corrections to abstracts until July 30, 2020, at 12:59 pm (CDT). Edits would include changing the title, adding or deleting authors, or changing the abstract body. Data for abstracts cannot be changed after the abstract submission site has closed. Once the review process begins no changes to the submissions are allowed – no exceptions. Please note that any typographical or spelling errors, improperly formatted titles, etc., will NOT be edited by anyone at the NANS office. It is the responsibility of the submitter to review and verify all work submitted.
Yes, if you have any charts, graphs, or images associated with your abstract, please upload them as .jpg, .gif, or .png file formats in the abstract submission form.
After the submission site is closed, only Abstract Submitters are able to log in to the submission site and see a “read-only” version of the abstract submission. It is highly encouraged to print or save a copy of your abstract submission before the submission site closes.
All accepted abstracts must submit an electronic poster (e-poster) of their abstract. E-posters will be available to view on monitors throughout the entire meeting. Accepted abstracts and e-posters will be available in the NANS Annual Meeting App. Abstracts and e-posters will also be available after the meeting on the NANS Annual Meeting webpage. They will be published exactly as they are submitted, with no exceptions. Please proofread your abstract before it is submitted to avoid errors.
Abstracts submitted for the 2021 NANS Annual Meeting will go through a blind review process by an independent scientific review committee and scored on scientific merit, originality, and relevance to the field of neuromodulation. Although scientific data is important, the quality of the abstract is the primary determinant for acceptance by the NANS Scientific Program Committee. The Scientific Program Committee has final discretion regarding abstract presentation format.
The Presenting Author of an Oral Presentation, Paper Poster Presentation, or an E-poster must register to attend the 2021 NANS Annual Meeting by Friday, December 4, 2020, for any accepted abstract to remain in the program. If the Presenting Author does not register by this date, all accepted abstracts by the Presenting Author will be declined. If not able to assume the responsibilities of Presenting Author, a Change of Presenting Author Form must be completed and submitted by Friday, November 20, 2020.
If the Presenting Author is not able to attend the meeting, a Change of Presenting Author Form must be completed and submitted. Please forward the completed form to LDeSchaaf@neuromodulation.org. No change will be made without receipt of the completed form, including updated disclosure information. Deadline to submit Change of Presenting Author Forms: Friday, November 20, 2020. After the change, all correspondence will then be addressed and sent to the new Presenting Author.
The Presenting Authors for all accepted abstracts (Oral Presentation, Paper Poster Presentation, and Electronic Poster) are responsible for all expenses associated with attending the Annual Meeting, including:
April 2020
July 2020
October 2020
November 2020
December 2020
January 2020
Visit the 2020 Annual Meeting website to claim CME or general attendance.